Literature DB >> 20551807

Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma.

Zhihua Liu1, Yukun Zhou, Peng Zhang, Huanlong Qin.   

Abstract

Surgical resection has been considered to be the best treatment for hepatocellular carcinoma (HCC). However, in recent years, there has been growing interest in the therapy of radiofrequency ablation (RFA). This meta-analysis is to evaluate the therapeutic effect of those 2 therapeutic methods. Outcomes evaluated were death rate, complications, survival rates, recurrence-free survival rates, and recurrence. Primary authors were contacted to retrieve further information if necessary. There is no significant difference in death rates of the treatment of HCC in the groups of hepatectomy and RFA, although the recurrence of HCC may be lower in the hepatectomy group. In the group of RFA, the recurrence rate in the previous site was higher but was lower in the new area, whereas it seems equal in the extrahepatic area. RFA may have comparable results with surgical resection in patients in the therapeutic effect of ablation for the treatment of HCC, if recurrence of HCC after RFA could be timely detected and effectively treated.

Entities:  

Mesh:

Year:  2010        PMID: 20551807     DOI: 10.1097/SLE.0b013e3181d823df

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  20 in total

Review 1.  Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.

Authors:  Meaghan S Dendy; Johannes M Ludwig; Stacey M Stein; Hyun S Kim
Journal:  Liver Cancer       Date:  2019-01-16       Impact factor: 11.740

2.  A measure to assess the ablative margin using 3D-CT image fusion after radiofrequency ablation of hepatocellular carcinoma.

Authors:  Hui Tang; Yunqiang Tang; Jian Hong; Tiejun Chen; Cong Mai; Peng Jiang
Journal:  HPB (Oxford)       Date:  2014-10-24       Impact factor: 3.647

Review 3.  Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.

Authors:  Jonathon Willatt; Kevin K Hannawa; Julie A Ruma; Timothy L Frankel; Dawn Owen; Pranab M Barman
Journal:  World J Hepatol       Date:  2015-02-27

4.  Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience.

Authors:  Koray Karabulut; Federico Aucejo; Hizir Yakup Akyildiz; Allan Siperstein; Eren Berber
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

5.  Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.

Authors:  Yo-Ichi Yamashita; Katsunori Imai; Takayoshi Kaida; Takanobu Yamao; Masayo Tsukamoto; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Takatoshi Ishiko; Tomoharu Yoshizumi; Tetsuo Ikeda; Yoshihiko Maehara; Hideo Baba
Journal:  Surg Endosc       Date:  2018-06-05       Impact factor: 4.584

Review 6.  Management of "very early" hepatocellular carcinoma on cirrhotic patients.

Authors:  Gonzalo Sapisochin; Elena Fernandez de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2014-11-27

7.  Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.

Authors:  Xiao-Li Wang; Kai Li; Zhong-Zhen Su; Ze-Ping Huang; Ping Wang; Rong-Qin Zheng
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 8.  Value of radiofrequency ablation in the treatment of hepatocellular carcinoma.

Authors:  Kai Feng; Kuan-Sheng Ma
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 9.  A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.

Authors:  Yaoping Shi; Bo Zhai
Journal:  Gastrointest Tumors       Date:  2016-04-28

10.  Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.

Authors:  Kai Li; Zhong-Zhen Su; Er-Jiao Xu; Jin-Xiu Ju; Xiao-Chun Meng; Rong-Qin Zheng
Journal:  BMC Cancer       Date:  2016-04-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.